Open AccessPrognostic Value of SARS-CoV-2 Anti-RBD IgG Antibody Quantitation on Clinical Outcomes in Hospitalized COVID-19 Patients
Author(s) -
Luai Madanat,
Melinda Sager,
Daniel O’Connor,
Bijaya Thapa,
Nishant Aggarwal,
Bipin Ghimire,
Carl B. Lauter,
Gabriel N. Maine,
Matthew Sims,
Alexandra Halalau
Publication year - 2022
Publication title -
international journal of general medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.722
H-Index - 36
ISSN - 1178-7074
DOI - 10.2147/ijgm.s370080
Subject(s) - medicine , antibody , covid-19 , titer , rank correlation , antibody titer , observational study , immunology , gastroenterology , disease , machine learning , computer science , infectious disease (medical specialty)
Antibody levels against SARS-CoV-2 can be used as an indicator of recent or past vaccination or infection. However, the prognostic value of antibodies targeting the receptor binding protein (anti-RBD) in hospitalized patients is not widely reported.